As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.
New data seems to show that GLP-1 medications like semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, are working on a population-wide level.
Last late week, health analytics or… [+3625 chars]
Last late week, health analytics or… [+3625 chars]